Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib, Bevacizumab, and Oxaliplatin in Metastatic Melanoma
NCT00538005Phase 2Unknown
- Sponsor
- San Diego Pacific Oncology & Hematology Associates
- Start
- May 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in Malignant Melanoma (MM), sponsored by San Diego Pacific Oncology & Hematology Associates. Status: unknown.
02
Drugs
sorafenib
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00538005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538005.